Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Microbot Medical Inc.NASDAQ: MBOT
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings remains negative
Q1 FY2026 retained earnings was -$107.76M, compared with -$93.55M a year earlier.
Context
- Retained earnings amounted to 138.0% of total assets at the end of Q1 FY2026, down 164.8 pp from a year earlier.
- Retained earnings grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether retained earnings keeps falling in the next quarterly balance sheet after a -15.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (104.09M) USD
- Year-over-year change
- -14.5%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (104.09M) | -14.5% |
| FY2024 | 2024-12-31 | (90.94M) | -14.4% |
| FY2023 | 2023-12-31 | (79.5M) | -15.6% |
| FY2022 | 2022-12-31 | (68.76M) | -23.7% |
| FY2021 | 2021-12-31 | (55.59M) | — |
Retained Earnings vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -15.2% is the 6th highest of 10, against a peer median of -12.1%.
- Retained earnings amounts to 138.0% of total assets for MBOT, versus a peer median of 366.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | -$85.12M USD | +53.8% | — | 31.7% | |
| Mar 2026 | -CA$91.46M CAD | -9.1% | — | 604.7% | |
| Mar 2026 | -$107.76M USD | -15.2% | — | 138.0% | |
| Mar 2026 | -$139.58M USD | -40.5% | — | 237.1% | |
| Mar 2026 | -$155.31M USD | -21.1% | — | 366.7% | |
| Mar 2026 | -$198.56M USD | -1737.3% | — | 94.9% | |
| Mar 2026 | -CA$224.47M CAD | -19.7% | — | 712.9% | |
| Mar 2026 | -$316.39M USD | -11.8% | — | 1460.4% | |
| Mar 2026 | -$338.7M USD | -7.7% | — | 150.1% | |
| Mar 2026 | -$419.01M USD | -12.1% | — | 812.9% | |
| Peer median (excluding MBOT) | — | -12.1% | — | 366.7% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.